Cargando…
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer
This study aimed to identify novel prognostic biomarker for advanced renal cell carcinoma (RCC) patients treated with anti-PD-1 therapy, using quantitative multi-immunofluorescence (IF) analysis of tumor immunity. Twenty-five consecutive patients who had metastatic or unresectable RCC treated with a...
Autores principales: | Kato, Renpei, Jinnouchi, Noriaki, Tuyukubo, Takashi, Ikarashi, Daiki, Matsuura, Tomohiko, Maekawa, Shigekatsu, Kato, Yoichiro, Kanehira, Mitsugu, Takata, Ryo, Ishida, Kazuyuki, Obara, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586238/ https://www.ncbi.nlm.nih.gov/pubmed/33129110 http://dx.doi.org/10.1016/j.tranon.2020.100918 |
Ejemplares similares
-
Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational study
por: Takata, Ryo, et al.
Publicado: (2021) -
Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting
por: Kato, Renpei, et al.
Publicado: (2020) -
Relationship between miR‐155 expression and clear cell papillary renal cell carcinoma in the dialyzed kidney
por: Shiomi, Ei, et al.
Publicado: (2021) -
Metastatic bladder cancer forming a sigmoidorectal fistula after enfortumab vedotin therapy: a case report
por: Tamada, Shinji, et al.
Publicado: (2023) -
Rapid progression of recurrent disease in a patient with renal cell carcinoma with vaginal metastasis
por: Hisano, Mizuki, et al.
Publicado: (2020)